PHARMA & LIFE SCIENCES: LATEST INTERVIEWS MORE INTERVIEWS
"We are taking a physical supply chain and creating a digital twin of products and data moving through the chain."
"Our focus on capacity utilization, market demand, and strategic acquisitions will be key drivers of TriRx's growth in the coming year."
"Pharma.Aero is a unique collaborative platform connecting life sciences shippers and service providers to achieve reliable end-to-end air transport for pharmaceutical cargo."
"Our technology and data capabilities help researchers and providers gain insights into health inequities and support strategies and solutions to advance health equity."
PHARMA & LIFE SCIENCES: LATEST ARTICLES
Funding Environment: Life Sciences Enter the Mainstream
April 20, 2021
The past 12 months been transformative for the life science industry in USA, and GBR explores how the funding environment has evolved to provide the influx of capital to sustain its innovations.
Turkey Pharmaceuticals: Bringing All Actors Together
June 17, 2020
Industry, university, investors - the two-way bridge to the knowledge gap.
PHARMA & LIFE SCIENCES: RECENTLY RELEASED PUBLICATIONS
MACIG
SPANISH
SUBSCRIBE TO OUR NEWSLETTER
RECENTLY PUBLISHED
MINPER 2023 - Perumin Official Investment Guide (Spanish Print Version)
GBR's MINPER: 2023: Official Investment Guide for Perumin, produced in strategic collaboration with the Peruvian Institute of Mining Engineers, delves into the themes impacting the Peruvian mining industry, based on over 130 interviews with leading executives from major producers, associations, juniors, consultants, and service providers, to provide a holistic analysis.
GBR's MINPER: 2023: Official Investment Guide for Perumin, produced in strategic collaboration with the Peruvian Institute of Mining Engineers, delves into the themes impacting the Peruvian mining industry, based on over 130 interviews with leading executives from major producers, associations, juniors, consultants, and service providers, to provide a holistic analysis.
PARTNER EVENTS
SUBSCRIBE TO OUR
NEWSLETTER
- Get GBR content delivered to your inbox
- Receive industry based news
- Completely free, e-mail only
